Festo Ruling May Have Broad Implications In Hatch/Waxman Reform Debate
This article was originally published in The Tan Sheet
Executive Summary
The Supreme Court's decision in the Festo case paves the way for continued debate on Hatch/Waxman patent reform, but could be a blow to generic drug firms